Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-08 3:07 pm Purchase | 2026-04-01 | 13G | LENZ THERAPEUTICS INC LENZ | Squarepoint Ops LLC | 1,593,246 5.100% | 1,593,246 (New Position) | Filing History |
| 2026-02-17 4:03 pm Sale | 2025-12-31 | 13G | LENZ THERAPEUTICS INC LENZ | Ridgeback Capital Investments L.P. | 0 0.000% | -1,951,875 (Position Closed) | Filing History |
| 2026-02-05 1:28 pm Sale | 2025-12-31 | 13G | LENZ THERAPEUTICS INC LENZ | FMR LLC | 3,702,718 11.800% | -575,526 (-13.45%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | LENZ THERAPEUTICS INC LENZ | BlackRock Inc. BLK | 1,537,723 4.900% | 94,859 (+6.57%) | Filing History |
| 2025-11-14 4:32 pm Sale | 2025-09-30 | 13G | LENZ THERAPEUTICS INC LENZ | Paradigm BioCapital Advisors LP | 1,073,461 3.800% | -346,371 (-24.40%) | Filing History |
| 2025-11-14 4:03 pm Sale | 2025-09-30 | 13G | LENZ THERAPEUTICS INC LENZ | Point72 Asset Management, L.P. | 1,357,751 4.800% | -524,942 (-27.88%) | Filing History |
| 2025-11-10 4:48 pm Sale | 2025-11-05 | 13D | LENZ THERAPEUTICS INC LENZ | Versant Venture Capital VI, L.P. | 1,050,599 3.400% | -132,944 (-11.23%) | Filing History |
| 2025-11-07 4:47 pm Purchase | 2025-11-05 | 13D | LENZ THERAPEUTICS INC LENZ | RA Capital Management, L.P. | 4,265,106 13.600% | 4,500 (+0.11%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | LENZ THERAPEUTICS INC LENZ | FMR LLC | 4,278,244 15.000% | 4,039,195 (+1689.69%) | Filing History |
| 2025-10-17 6:13 pm Purchase | 2025-09-30 | 13G | LENZ THERAPEUTICS INC LENZ | BlackRock Inc. BLK | 1,442,864 5.100% | 1,442,864 (New Position) | Filing History |
| 2025-09-22 4:20 pm Sale | 2025-09-18 | 13D | LENZ THERAPEUTICS INC LENZ | Versant Venture Capital VI, L.P. | 1,183,543 4.100% | -216,677 (-15.47%) | Filing History |
| 2025-08-20 5:13 pm Sale | 2025-08-18 | 13D | LENZ THERAPEUTICS INC LENZ | Versant Venture Capital VI, L.P. | 1,400,220 4.900% | -175,679 (-11.15%) | Filing History |
| 2025-07-14 4:50 pm Sale | 2025-07-10 | 13D | LENZ THERAPEUTICS INC LENZ | Versant Venture Capital VI, L.P. | 1,575,899 5.600% | -391,376 (-19.89%) | Filing History |
| 2025-06-24 4:21 pm Sale | 2025-06-20 | 13D | LENZ THERAPEUTICS INC LENZ | Versant Venture Capital VI, L.P. | 1,967,275 7.000% | -133,924 (-6.37%) | Filing History |
| 2025-06-12 4:49 pm Unchanged | 2025-06-10 | 13D | LENZ THERAPEUTICS INC LENZ | Versant Venture Capital VI, L.P. | 2,101,199 7.500% | 0 (Unchanged) | Filing History |
| 2025-05-09 4:19 pm Purchase | 2025-05-07 | 13D | LENZ THERAPEUTICS INC LENZ | RA Capital Management, L.P. | 4,260,606 15.100% | 9,750 (+0.23%) | Filing History |
| 2025-03-27 4:21 pm Purchase | 2025-03-20 | 13G | LENZ THERAPEUTICS INC LENZ | Paradigm BioCapital Advisors LP | 1,419,832 5.200% | 1,419,832 (New Position) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | LENZ THERAPEUTICS INC LENZ | TANG CAPITAL MANAGEMENT, LLC | 766,940 2.800% | 766,940 (New Position) | Filing History |
| 2024-11-08 5:08 pm Unchanged | 2024-08-14 | 13D | LENZ THERAPEUTICS INC LENZ | Versant Venture Capital VI, L.P. | 2,101,199 7.600% | 0 (Unchanged) | Filing History |
| 2024-07-29 4:12 pm Purchase | 2024-07-17 | 13G | LENZ THERAPEUTICS INC LENZ | Ridgeback Capital Investments L.P. | 1,951,875 7.200% | 1,951,875 (New Position) | Filing History |